ALK-Abello AS - Company Profile
Powered by 
All the sales intelligence you need on ALK-Abello AS in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how ALK-Abello AS fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with ALK-Abello AS.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
ALK-Abello AS Catalyst Calendar
Proactively evaluate ALK-Abello AS’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of ALK-Abello AS Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 06 Dec 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 01 Nov 2020 | Phase II Trial Initiation | ALK-Abello AS; Division of Allergy Immunology and Transplantation; Immune Tolerance Network; PPD Inc; Regeneron Pharmaceuticals Inc; Rho Inc; The National Institute of Allergy and Infectious Diseases | ALK B; REGN | dupilumab; standardized grass pollen [timothy (Phleum pratense)] allergen extract | Immunology; Ophthalmology; Respiratory | Allergic Rhino-Conjunctivitis; Grass Pollen Allergy; Seasonal Allergic Rhinitis | Clinical Trial Registry |
| 31 Oct 2020 | Phase II Trial Completion | Center Laboratories Inc | 4123 | CS-02 | Metabolic Disorders | Type 2 Diabetes | Clinical Trial Registry |
| 01 Jun 2020 | Phase IV Trial Initiation | Abbott Laboratories; ALK-Abello AG | ABT | standardized mite (Dermatophagoides pteronyssinus + Dermatophagoides farinae) allergen extract | Immunology; Respiratory | Allergic Asthma; Allergic Rhinitis; House Dust Mite Allergy | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer